ペプチド合成市場：製品、技術、エンドユーザー別-2025-2030年の世界予測

ペプチド合成市場は、2023年に6億3,671万米ドルと評価され、2024年には6億8,344万米ドルに達すると予測され、CAGR 7.84%で成長し、2030年には10億8,042万米ドルに達すると予測されています。

ペプチド合成は、バイオテクノロジーと医薬品において極めて重要なプロセスであり、様々な生物学的機能において重要な役割を果たすアミノ酸で構成される化合物であるペプチドの創製に関与します。ペプチド合成の必要性は、医薬品開発、診断、治療への応用に起因しており、ペプチドベースの医薬品の設計、酵素研究、ワクチン開発に不可欠です。その最終用途は、製薬、バイオテクノロジー、学術研究機関などの業界に及んでいます。ペプチド合成市場の成長は、医薬品研究開発への投資の増加、慢性疾患の流行、固相合成や液相合成などの合成技術の進歩に大きく影響されています。ペプチド合成装置における自動化と小型化の強化は、効率改善とコスト削減によって市場拡大の大きなチャンスをもたらします。ペプチドがカスタム治療のアプローチに使用される機会が増えていることから、個別化医療に大きなチャンスがあります。しかし、合成コストの高さ、複雑な規制当局の承認、ペプチドの安定性や溶解性の問題といった課題が、市場の成長を阻害する可能性があります。さらに、合成プロセスに必要な技術的専門知識やスケーラビリティの懸念からも限界が生じる。これらの課題に対抗するため、企業は合成機技術、ペプチド修飾技術、ペプチド溶解性ソリューションなどの分野で技術革新を行うことができます。さらに、安定した長時間作用型ペプチド製剤の開発に焦点を当てた研究により、既存の安定性の問題に対処できる可能性があります。ペプチドのバイオアベイラビリティとターゲティング能力の強化に注力することで、ペプチドの治療応用をさらに促進することができます。市場はまた、既存プレーヤーと新興企業の両方が自社の製品を差別化するためのイノベーションに注力する競争力学を特徴としています。したがって、企業は研究機関やバイオテクノロジー企業との戦略的提携や共同研究を優先し、ペプチド治療薬の新たな機会を活用することで、市場への浸透と成長を加速させることができます。

市場力学：急速に進化するペプチド合成市場の主要市場インサイトを公開

ペプチド合成市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ペプチド治療薬のニーズと用途の増加
  • 各国における製薬研究活動および資金の増加
  • 化粧品業界からの生理活性ペプチドに対する需要の高まり
• 市場抑制要因
  • 標準的なペプチド設計規則や規制の欠如
• 市場機会
  • 先進的なペプチド合成機とペプチド設計技術の開発
  • 栄養補助食品と食品保存におけるペプチドの新たな応用
• 市場の課題
  • ペプチド開発の難しさとペプチドの不安定性

ポーターのファイブフォース：ペプチド合成市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ペプチド合成市場における外部からの影響の把握

外部マクロ環境要因は、ペプチド合成市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ペプチド合成市場における競合情勢の把握

ペプチド合成市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスペプチド合成市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ペプチド合成市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ペプチド合成市場における成功への道筋を描く

ペプチド合成市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペプチド治療薬の需要と応用の高まり
    • 経済全体における医薬品調査活動と資金の増加
    • 化粧品業界からの生理活性ペプチドの需要増加
  • 抑制要因
    • 標準的なペプチド設計のルールと規制の欠如
  • 機会
    • 高度なペプチド合成装置とペプチド設計技術の開発
    • 栄養補助食品と食品保存におけるペプチドの新たな応用
  • 課題
    • ペプチドの開発の難しさとペプチドの不安定性
• 市場セグメンテーション分析
  • 製品：合成中にペプチド結合を形成するための試薬の使用が増加
  • 技術：ペプチドの収量と純度が高いため、ハイブリスと組み換え技術の潜在能力が高まっている
  • エンドユーザー：製薬会社およびバイオ製薬会社による新薬発見のためのペプチド合成の使用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ペプチド合成市場：製品別

• 装置
  • クロマトグラフィー装置
  • 凍結乾燥装置
  • ペプチド合成装置
• 試薬
  • アミノ酸
  • ベース樹脂
  • ペプチドカップリング試薬
  • ペプチド標識試薬
• サービス

第7章 ペプチド合成市場：技術別

• ハイブリッドおよび組み換え技術
• 固相ペプチド合成
• 溶液相合成

第8章 ペプチド合成市場：エンドユーザー別

• 学術調査機関
• 受託開発製造組織/受託調査組織
• 製薬・バイオテクノロジー企業

第9章 南北アメリカのペプチド合成市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のペプチド合成市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのペプチド合成市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • BiosynthがPepceuticalsの買収によりペプチド合成の提供を拡大
  • ジェンスクリプト、ネオアンチゲンペプチドとAPIを含むペプチド生産能力を拡大
  • Mesa Labs、Belynticのペプチド精製事業を買収
• 戦略分析と提言

企業一覧

• 2B Scientific Limited
• AAPPTec
• ABclonal, Inc.
• Advanced ChemTech
• Almac Group Limited
• AmbioPharm Inc.
• AnaSpec Inc.
• Bachem AG
• Biocon Limited
• Biosynth Ltd.
• Biotage
• CEM Corporation
• CPC Scientific Inc.
• Creative Diagnostics
• Creative Peptides
• CSBio
• Enamine Ltd.
• GenScript Biotech Corporation
• Gyros Protein Technologies AB
• Hybio Pharmaceutical Co., Ltd.
• JPT Peptide Technologies GmbH by TheraCode GmbH
• Kaneka Corporation
• LifeTein LLC
• Merck KGaA
• New England BioGroup, LLC
• Novo Nordisk A/S
• PolyPeptide Group AG
• Thermo Fisher Scientific Inc.
• USV Private Limited

LIST OF FIGURES

• FIGURE 1. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
• FIGURE 2. PEPTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
• TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY BASE RESINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID & RECOMBINANT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION/CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

The Peptide Synthesis Market was valued at USD 636.71 million in 2023, expected to reach USD 683.44 million in 2024, and is projected to grow at a CAGR of 7.84%, to USD 1,080.42 million by 2030.

Peptide synthesis, a pivotal process in biotechnology and pharmaceuticals, involves the creation of peptides, compounds comprised of amino acids that play critical roles in various biological functions. The necessity of peptide synthesis stems from its applications in drug development, diagnostics, and therapeutics, making it vital for designing peptide-based drugs, enzyme research, and developing vaccines. Its end-use scope spans across industries such as pharmaceuticals, biotechnology, and academic research institutions. Growth in the peptide synthesis market is significantly influenced by increased investment in pharmaceutical R&D, rising prevalence of chronic diseases, and advancements in synthesis technologies such as solid-phase and liquid-phase synthesis. Enhanced automation and miniaturization in peptide synthesizers present considerable opportunities for market expansion by improving efficiency and reducing costs. A major opportunity lies in personalized medicine, as peptides increasingly are used for custom therapeutic approaches. However, challenges such as the high cost of synthesis, complex regulatory approvals, and issues with peptide stability and solubility can impede market growth. Limitations further arise from the technical expertise required for synthesis processes and scalability concerns. To counter these challenges, companies can innovate in areas like synthesizer technology, peptide modification techniques, and peptide solubility solutions. Additionally, research focusing on developing stable, long-acting peptide formulations could address existing stability issues. Focusing on enhancing bioavailability and targeting capabilities of peptides can further drive their therapeutic applications. The market is also characterized by competitive dynamics with both established players and startups focusing on innovation to differentiate their offerings. Consequently, businesses should prioritize strategic partnerships and collaborations with research institutions and biotech firms to take advantage of emerging opportunities in peptide therapeutics, thereby fostering accelerated market penetration and growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peptide Synthesis Market

The Peptide Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Higher need and applications of peptide therapeutics
  • Increase in pharmaceutical research activities and funding across economies
  • Growing demand for bioactive peptides from the cosmetics industry
• Market Restraints
  • Lack of standard peptide design rules and regulations
• Market Opportunities
  • Development of advanced peptide synthesizers and technologies for peptide design
  • Emerging applications of peptides in nutraceuticals and food preservation
• Market Challenges
  • Difficulty in development of peptides and instability of the peptides

Porter's Five Forces: A Strategic Tool for Navigating the Peptide Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peptide Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peptide Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peptide Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peptide Synthesis Market

A detailed market share analysis in the Peptide Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peptide Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peptide Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peptide Synthesis Market

A strategic analysis of the Peptide Synthesis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Market Segmentation & Coverage

This research report categorizes the Peptide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Equipment, Reagents, and Services. The Equipment is further studied across Chromatography Equipment, Lyophilizers, and Peptide Synthesizers. The Reagents is further studied across Amino Acids, Base Resins, Peptide Coupling Reagents, and Peptide Labeling Reagents.
• Based on Technology, market is studied across Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, and Solution-Phase Synthesis.
• Based on End User, market is studied across Academic & Research Institutes, Contract Development & Manufacturing Organization/Contract Research Organization, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Higher need and applications of peptide therapeutics
    • 5.1.1.2. Increase in pharmaceutical research activities and funding across economies
    • 5.1.1.3. Growing demand for bioactive peptides from the cosmetics industry
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standard peptide design rules and regulations
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of advanced peptide synthesizers and technologies for peptide design
    • 5.1.3.2. Emerging applications of peptides in nutraceuticals and food preservation
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulty in development of peptides and instability of the peptides
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of reagents for forming peptide bonds during synthesis
  • 5.2.2. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
  • 5.2.3. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Peptide Synthesis Market, by Product

• 6.1. Introduction
• 6.2. Equipment
  • 6.2.1. Chromatography Equipment
  • 6.2.2. Lyophilizers
  • 6.2.3. Peptide Synthesizers
• 6.3. Reagents
  • 6.3.1. Amino Acids
  • 6.3.2. Base Resins
  • 6.3.3. Peptide Coupling Reagents
  • 6.3.4. Peptide Labeling Reagents
• 6.4. Services

7. Peptide Synthesis Market, by Technology

• 7.1. Introduction
• 7.2. Hybrid & Recombinant Technology
• 7.3. Solid-Phase Peptide Synthesis
• 7.4. Solution-Phase Synthesis

8. Peptide Synthesis Market, by End User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Contract Development & Manufacturing Organization/Contract Research Organization
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Peptide Synthesis Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Peptide Synthesis Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Peptide Synthesis Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
  • 12.3.2. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
  • 12.3.3. Mesa Labs Acquires Belyntic's Peptide Purification Business
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 2B Scientific Limited
• 2. AAPPTec
• 3. ABclonal, Inc.
• 4. Advanced ChemTech
• 5. Almac Group Limited
• 6. AmbioPharm Inc.
• 7. AnaSpec Inc.
• 8. Bachem AG
• 9. Biocon Limited
• 10. Biosynth Ltd.
• 11. Biotage
• 12. CEM Corporation
• 13. CPC Scientific Inc.
• 14. Creative Diagnostics
• 15. Creative Peptides
• 16. CSBio
• 17. Enamine Ltd.
• 18. GenScript Biotech Corporation
• 19. Gyros Protein Technologies AB
• 20. Hybio Pharmaceutical Co., Ltd.
• 21. JPT Peptide Technologies GmbH by TheraCode GmbH
• 22. Kaneka Corporation
• 23. LifeTein LLC
• 24. Merck KGaA
• 25. New England BioGroup, LLC
• 26. Novo Nordisk A/S
• 27. PolyPeptide Group AG
• 28. Thermo Fisher Scientific Inc.
• 29. USV Private Limited